Case Studies

Real engagements, measurable outcomes.

How we partner with discovery teams to deliver lead candidates — from hit triage to wet-lab confirmation — under real-world timelines.

[ Case Study ]

In Silico Residue Scanning Guides Affinity Maturation

Using Schrödinger BioLuminate to systematically scan interface residues and identify tunable positions for affinity improvement.

2026

Download Case Study

[ Case Study ]

From Aggregation Hotspot Prediction to Risk Mitigation: Improving MEDI-1912 Developability

Structure-guided aggregation risk mitigation using Schrödinger BioLuminate to improve antibody developability and reduce aggregation propensity.

2026

Download Case Study

[ Case Study ]

AI-Driven Mapping of the HER2-Herceptin Antibody-Antigen Interface

Using AI-driven structural modeling, we mapped the HER2-Herceptin antibody-antigen interface to identify critical binding determinants and accelerate data-driven antibody development.

2026

Download Case Study

[ Case Study ]

High-Throughput Antibody Expression Optimization

A scalable workflow for rapidly screening, expressing, and selecting high-quality antibody candidates for downstream development.

2026

Download Case Study